CXCL12 / CXCR4 / CXCR7 chemokine axis and cancer progression

Xueqing Sun, Guangcun Cheng, Mingang Hao, Jianghua Zheng, Xiaoming Zhou, Jian Zhang, Russell S. Taichman, Kenneth Pienta, Jianhua Wang

Research output: Contribution to journalArticle

Abstract

Chemokines, small pro-inflammatory chemoattractant cytokines that bind to specific G-protein-coupled seven-span transmembrane receptors, are major regulators of cell trafficking and adhesion. The chemokine CXCL12 (also called stromal-derived factor-1) is an important α-chemokine that binds primarily to its cognate receptor CXCR4 and thus regulates the trafficking of normal and malignant cells. For many years, it was believed that CXCR4 was the only receptor for CXCL12. Yet, recent work has demonstrated that CXCL12 also binds to another seven-transmembrane span receptor called CXCR7. Our group and others have established critical roles for CXCR4 and CXCR7 on mediating tumor metastasis in several types of cancers, in addition to their contributions as biomarkers of tumor behavior as well as potential therapeutic targets. Here, we review the current concepts regarding the role of CXCL12 / CXCR4 / CXCR7 axis activation, which regulates the pattern of tumor growth and metastatic spread to organs expressing high levels of CXCL12 to develop secondary tumors. We also summarize recent therapeutic approaches to target these receptors and/or their ligands.

Original languageEnglish (US)
Pages (from-to)709-722
Number of pages14
JournalCancer and Metastasis Reviews
Volume29
Issue number4
DOIs
StatePublished - Dec 2010
Externally publishedYes

Fingerprint

Chemokines
Neoplasms
CXCR4 Receptors
Chemokine CXCL12
Chemotactic Factors
Tumor Biomarkers
Cell Adhesion
Cytokines
Neoplasm Metastasis
Ligands
Therapeutics
Growth

Keywords

  • Cancer progression
  • Chemokines
  • CXCL12 / CXCR4 / CXCR7 chemokine axis

ASJC Scopus subject areas

  • Oncology
  • Cancer Research

Cite this

Sun, X., Cheng, G., Hao, M., Zheng, J., Zhou, X., Zhang, J., ... Wang, J. (2010). CXCL12 / CXCR4 / CXCR7 chemokine axis and cancer progression. Cancer and Metastasis Reviews, 29(4), 709-722. https://doi.org/10.1007/s10555-010-9256-x

CXCL12 / CXCR4 / CXCR7 chemokine axis and cancer progression. / Sun, Xueqing; Cheng, Guangcun; Hao, Mingang; Zheng, Jianghua; Zhou, Xiaoming; Zhang, Jian; Taichman, Russell S.; Pienta, Kenneth; Wang, Jianhua.

In: Cancer and Metastasis Reviews, Vol. 29, No. 4, 12.2010, p. 709-722.

Research output: Contribution to journalArticle

Sun, X, Cheng, G, Hao, M, Zheng, J, Zhou, X, Zhang, J, Taichman, RS, Pienta, K & Wang, J 2010, 'CXCL12 / CXCR4 / CXCR7 chemokine axis and cancer progression', Cancer and Metastasis Reviews, vol. 29, no. 4, pp. 709-722. https://doi.org/10.1007/s10555-010-9256-x
Sun, Xueqing ; Cheng, Guangcun ; Hao, Mingang ; Zheng, Jianghua ; Zhou, Xiaoming ; Zhang, Jian ; Taichman, Russell S. ; Pienta, Kenneth ; Wang, Jianhua. / CXCL12 / CXCR4 / CXCR7 chemokine axis and cancer progression. In: Cancer and Metastasis Reviews. 2010 ; Vol. 29, No. 4. pp. 709-722.
@article{2fff3c87790b477ba065a509be11407d,
title = "CXCL12 / CXCR4 / CXCR7 chemokine axis and cancer progression",
abstract = "Chemokines, small pro-inflammatory chemoattractant cytokines that bind to specific G-protein-coupled seven-span transmembrane receptors, are major regulators of cell trafficking and adhesion. The chemokine CXCL12 (also called stromal-derived factor-1) is an important α-chemokine that binds primarily to its cognate receptor CXCR4 and thus regulates the trafficking of normal and malignant cells. For many years, it was believed that CXCR4 was the only receptor for CXCL12. Yet, recent work has demonstrated that CXCL12 also binds to another seven-transmembrane span receptor called CXCR7. Our group and others have established critical roles for CXCR4 and CXCR7 on mediating tumor metastasis in several types of cancers, in addition to their contributions as biomarkers of tumor behavior as well as potential therapeutic targets. Here, we review the current concepts regarding the role of CXCL12 / CXCR4 / CXCR7 axis activation, which regulates the pattern of tumor growth and metastatic spread to organs expressing high levels of CXCL12 to develop secondary tumors. We also summarize recent therapeutic approaches to target these receptors and/or their ligands.",
keywords = "Cancer progression, Chemokines, CXCL12 / CXCR4 / CXCR7 chemokine axis",
author = "Xueqing Sun and Guangcun Cheng and Mingang Hao and Jianghua Zheng and Xiaoming Zhou and Jian Zhang and Taichman, {Russell S.} and Kenneth Pienta and Jianhua Wang",
year = "2010",
month = "12",
doi = "10.1007/s10555-010-9256-x",
language = "English (US)",
volume = "29",
pages = "709--722",
journal = "Cancer and Metastasis Reviews",
issn = "0167-7659",
publisher = "Springer Netherlands",
number = "4",

}

TY - JOUR

T1 - CXCL12 / CXCR4 / CXCR7 chemokine axis and cancer progression

AU - Sun, Xueqing

AU - Cheng, Guangcun

AU - Hao, Mingang

AU - Zheng, Jianghua

AU - Zhou, Xiaoming

AU - Zhang, Jian

AU - Taichman, Russell S.

AU - Pienta, Kenneth

AU - Wang, Jianhua

PY - 2010/12

Y1 - 2010/12

N2 - Chemokines, small pro-inflammatory chemoattractant cytokines that bind to specific G-protein-coupled seven-span transmembrane receptors, are major regulators of cell trafficking and adhesion. The chemokine CXCL12 (also called stromal-derived factor-1) is an important α-chemokine that binds primarily to its cognate receptor CXCR4 and thus regulates the trafficking of normal and malignant cells. For many years, it was believed that CXCR4 was the only receptor for CXCL12. Yet, recent work has demonstrated that CXCL12 also binds to another seven-transmembrane span receptor called CXCR7. Our group and others have established critical roles for CXCR4 and CXCR7 on mediating tumor metastasis in several types of cancers, in addition to their contributions as biomarkers of tumor behavior as well as potential therapeutic targets. Here, we review the current concepts regarding the role of CXCL12 / CXCR4 / CXCR7 axis activation, which regulates the pattern of tumor growth and metastatic spread to organs expressing high levels of CXCL12 to develop secondary tumors. We also summarize recent therapeutic approaches to target these receptors and/or their ligands.

AB - Chemokines, small pro-inflammatory chemoattractant cytokines that bind to specific G-protein-coupled seven-span transmembrane receptors, are major regulators of cell trafficking and adhesion. The chemokine CXCL12 (also called stromal-derived factor-1) is an important α-chemokine that binds primarily to its cognate receptor CXCR4 and thus regulates the trafficking of normal and malignant cells. For many years, it was believed that CXCR4 was the only receptor for CXCL12. Yet, recent work has demonstrated that CXCL12 also binds to another seven-transmembrane span receptor called CXCR7. Our group and others have established critical roles for CXCR4 and CXCR7 on mediating tumor metastasis in several types of cancers, in addition to their contributions as biomarkers of tumor behavior as well as potential therapeutic targets. Here, we review the current concepts regarding the role of CXCL12 / CXCR4 / CXCR7 axis activation, which regulates the pattern of tumor growth and metastatic spread to organs expressing high levels of CXCL12 to develop secondary tumors. We also summarize recent therapeutic approaches to target these receptors and/or their ligands.

KW - Cancer progression

KW - Chemokines

KW - CXCL12 / CXCR4 / CXCR7 chemokine axis

UR - http://www.scopus.com/inward/record.url?scp=78449300594&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=78449300594&partnerID=8YFLogxK

U2 - 10.1007/s10555-010-9256-x

DO - 10.1007/s10555-010-9256-x

M3 - Article

VL - 29

SP - 709

EP - 722

JO - Cancer and Metastasis Reviews

JF - Cancer and Metastasis Reviews

SN - 0167-7659

IS - 4

ER -